Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recombinant Chicken Ephrin Type-A Receptor 5 (EPHA5)

Cat. No.AP4C683

Product TypeAnimal Proteins

Size

Product Overview

BioVenic's Recombinant Chicken Ephrin Type-A Receptor 5 (EPHA5) is a recombinant protein expressed from E.coli. Its predicted molecular weight is 112.2 kDa. The purity is>85% (SDS-PAGE).

Specifications

Type Recombinant Protein
Species Chicken
Expression System E.coli
Purity >85% (SDS-PAGE)
Predicted Molecular Weight 112.2 kDa
Physical State Lyophilized
Formulation Tris/PBS-based buffer, 5%-50% glycerol.

Target Information

Chicken Ephrin Type-A Receptor 5 (EPHA5) is a receptor tyrosine kinase that plays a crucial role in neural development and synaptic plasticity. It is highly expressed in the nervous system, particularly in the retina, olfactory bulb, cerebral cortex, hippocampus, and spinal cord. EPHA5 is involved in axon guidance, dendritic spine formation, and neural plasticity, which are essential for proper brain development and function. In chickens, EPHA5 is likely to be involved in similar processes, contributing to the development and maintenance of the nervous system. Abnormal expression or function of EPHA5 has been implicated in various neurological disorders and cancers.

Protein Chicken Ephrin Type-A Receptor 5 (EPHA5)
Protein Synonym EPH-like kinase 7; EK7; cEK7
Gene ID 395997
EC No. P54755

Shipping and Storage

This product is shipped with ice packs. Lyophilized protein can be stored at -80°C for 1 year. After reconstitution, the protein solution can be stored at 2-8°C for 2-7 days.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

User Note

  1. Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL. Aliquot the reconstituted solution to minimize freeze-thaw cycles.
Inquiry Basket